Katrin Georgi

Katrin Georgi currently serves as VP and Head of Preclinical Development Leads at Bayer, overseeing global strategic responsibilities for preclinical test strategies across all R&D programs. Prior to this role, Katrin held various leadership positions at Merck, including VP and Head of DMPK, where responsibilities encompassed providing strategic NCE DMPK support, leading a diverse team, and ensuring accountability for pivotal CTD sections. Earlier career experiences include roles as Chief of Staff within Quantitative Pharmacology, a Principal Scientist in discovery DMPK, and postdoctoral positions at both WHO and UC Davis, focusing on pharmacokinetics and metabolomics. Katrin holds a doctorate in Analytical Chemistry from Ludwig-Maximilians-Universität München and a Diplom in Chemistry from Leipzig University.